iPSCs ‐derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Wei-Zhou Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Provincial Key Laboratory of Public Health and Biosafety and School of Public Health, The First Affiliated Hospital of Kunming Medical Univers…. Hauptthemen laut MEDLINE: Osteoporosis, Mesenchymal Stem Cells, Ovariectomy, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kunming Medical University Student Innovation and Entrepreneurship Training Program Project, the National Natural Science Foundation of China, Major Science and Technology Project of Yunnan Provincial Department of Science and Technology, Yunnan Provincial Orthopedic and Sports Rehabilitation Clinical….
Abstract (Originalsprache)
Osteoporosis is a metabolic bone disease that seriously jeopardizes the health of middle‐aged and elderly people. Mesenchymal stem cell‐based transplantation for osteoporosis is a promising new therapeutic strategy. Induced mesenchymal stem cells (iMSCs) are a new option for stem cell transplantation therapy. Acquired mouse skin fibroblasts were transduced and reprogrammed into induced pluripotent cells and further induced to differentiate into iMSCs. The iMSCs were tested for pluripotency markers, trilineage differentiation ability, cell surface molecular marker tests, and gene expression patterns. The iMSCs were injected into the tail vein of mice by tail vein injection, and the distribution of cells in various organs was observed. The effect of iMSCs on the bone mass of mice was detected after injection into the mouse osteoporosis model. The effects of iMSCs infusion on metabolites in femoral tissue and peripheral blood plasma were detected based on LC–MS untargeted metabolomics. iMSCs have similar morphology, immunophenotype, in vitro differentiation potential, and gene expression patterns as mesenchymal stem cells. The iMSCs were heavily distributed in the lungs after infusion and gradually decreased over time. The iMSCs in the femoral bone marrow cavity gradually increased with time. iMSCs infusion significantly avoided bone loss due to oophorectomy. The results of untargeted metabolomics suggest that amino acid and lipid metabolic pathways are key factors involved in iMSCs bone protection and prevention of osteoporosis formation. iMSCs obtained by reprogramming‐induced differentiation had cellular properties similar to those of bone marrow mesenchymal stem cells. The iMSCs could promote the remodelling of bone structure in ovariectomy‐induced osteoporotic mice and affect the changes of several key metabolites in bone and peripheral blood. Some of these metabolites can serve as potential biomarkers and therapeutic targets for iMSCs intervention in osteoporosis. Investigating the effects of iMSCs on osteoporosis and the influence of metabolic pathways will provide new ideas and methods for the clinical treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Provincial Key Laboratory of Public Health and Biosafety and School of Public Health, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Department of Orthopedics, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Department of Radiology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
- Department of Orthopedics, Kunming Medical University Affiliated Qujing Hospital, Qujing, Yunnan, China.
- Department of Colorectal Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Wei-Zhou Wang, Ding-You You
Förderung
- Kunming Medical University Student Innovation and Entrepreneurship Training Program Project
- the National Natural Science Foundation of China
- Major Science and Technology Project of Yunnan Provincial Department of Science and Technology, Yunnan Provincial Orthopedic and Sports Rehabilitation Clinical…
- Yunnan Province Department of Science and Technology-Kunming Medical University Joint Special Project
- the Doctoral Research Fund Project of the First Affiliated Hospital of Kunming Medical University
- National Natural Science Foundation of China
Zitieren
APA
Wang, W. Z., Wang, Y. H., Bao, S. S., He, F., Li, G., Yang, G., Chen, J., Yang, X. Y., Xiao, Y., Tong, Y. S., Zhao, X. T., Hu, J., & You, D. Y. (2024). iPSCs ‐derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70200
Vancouver
Wang WZ, Wang YH, Bao SS, He F, Li G, Yang G, et al. iPSCs ‐derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70200
BibTeX
@article{Wang2024,
author = {Wang, Wei-Zhou and Wang, Yang-Hao and Bao, Sha-Sha and He, Fei and Li, Guoyu and Yang, Guang and Chen, Jing and Yang, Xin-Yu and Xiao, Ya and Tong, Ya-Shuang and Zhao, Xue-Ting and Hu, Jun and You, Ding-You},
title = {iPSCs ‐derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70200}
}
EUVIMED